Patents by Inventor Bradford Sippy

Bradford Sippy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240000815
    Abstract: Provided herein are pharmaceutical compositions comprising deuterated derivatives of psilocybin. The provided compositions may be useful for treating and/or preventing various diseases and conditions, such as mood or psychiatric disorders.
    Type: Application
    Filed: July 18, 2023
    Publication date: January 4, 2024
    Inventor: Bradford Sippy
  • Patent number: 11324762
    Abstract: Provided herein are pharmaceutical compositions comprising deuterated derivatives of psilocybin. The provided compositions may be useful for treating and/or preventing various diseases and conditions, such as mood or psychiatric disorders.
    Type: Grant
    Filed: August 19, 2021
    Date of Patent: May 10, 2022
    Assignee: Lennham Pharmaceuticals, Inc.
    Inventor: Bradford Sippy
  • Publication number: 20220110956
    Abstract: Provided herein are pharmaceutical compositions comprising deuterated derivatives of psilocybin. The provided compositions may be useful for treating and/or preventing various diseases and conditions, such as mood or psychiatric disorders.
    Type: Application
    Filed: August 19, 2021
    Publication date: April 14, 2022
    Inventor: Bradford Sippy
  • Publication number: 20220110955
    Abstract: Provided herein are pharmaceutical compositions comprising deuterated derivatives of psilocybin. The provided compositions may be useful for treating and/or preventing various diseases and conditions, such as mood or psychiatric disorders.
    Type: Application
    Filed: April 15, 2021
    Publication date: April 14, 2022
    Inventor: Bradford Sippy
  • Patent number: 11000534
    Abstract: Provided herein are pharmaceutical compositions comprising deuterated derivatives of psilocybin. The provided compositions may be useful for treating and/or preventing various diseases and conditions, such as mood or psychiatric disorders.
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: May 11, 2021
    Assignee: Lennham Pharmaceuticals, Inc.
    Inventor: Bradford Sippy
  • Publication number: 20100169204
    Abstract: The present invention describes the creation of derivative financial products such as options, futures, and other derivatives whereby the underlying asset of the derivative is based on a Third Party Data performance indicator, such as unit volume or market share, of one or more retail product(s). The invention further describes the creation of derivatives for retail products whereby non-investor consumers of retail products can participate in the market for said derivatives.
    Type: Application
    Filed: June 8, 2008
    Publication date: July 1, 2010
    Inventors: Bradford Sippy, Paresh Patel